ELVN   $23.24  0.74% Market Closed After Close 23.19 -0.22%

Enliven Therapeutics Inc
Total Cash 312.39M
totalCashPerShare 6.613
EBITDA -95.95M
Total Debt 169.00K
quickRatio 14.132
currentRatio 14.392
Total Revenue
debtToEquity 0.055
Revenue/Share
ROA -0.19549
ROE -0.28369
grossProfits
freeCashflow -31.10M
operatingCashflow -72.17M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 744.95M
forwardPE -9.324999
floatShares 24.86M
sharesOutstanding 47.24M
sharesShort 5.35M
sharesShortPriorMonth 5.30M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.07%
heldPercentInstitutions 1.02%
Short Ratio help_outline 31.30%
shortPercentOfFloat 0.28%
impliedSharesOutstanding
bookValue 6.464
Price To Book help_outline 3.46
earningsQuarterlyGrowth
netIncomeToCommon -82.83M
trailingEps -1.92%
forwardEps -2.40%
enterpriseToEbitda -7.76
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.5 3Q 2024
institutionsCount 144
lastUpdated Sept. 17, 2024, 2:44 a.m.